Business Standard

Lupin gets USFDA nod to market oral contraceptive

The sales of the tablet were approximately $103.6 million in the US market

Read more on:    Lupin | Usfda | Lutera Tablet
Related News

Pharma major Ltd has received the final approval from the United States Food and Drugs Administration () to market a generic version of an oral conceptive called Lutera Tablets.

The sales of the tablet were approximately $103.6 million in the US market and Lupin will begin marketing the generic version shortly, the company said.

Lupin is the fifth largest generics player in the US with a share of 5.1%. It is a significant player in the cardiovascular, diabetology, asthma and pediatric segments, holding global leadership in the anti-tuberculosis area.

Read more on:   
|
|

Read More

Suzlon, Tanti, 4 company execs settle charges with Sebi

After they together paid Rs 12 lakh to settle charges related to alleged delay in amending insider trading norms


Quick Links

Back to Top